Inventor · disambiguated record
Andre Chollet
Also filed as: CHOLLET ANDRE · CHOLLET ANDRÉ
9 granted patents·5 pending applications·29 citations·filing 2014–2023
86Inventor score
Files withObsEva SA14
Top patents by PatentIndex Score
14 records- 0190US9670155B2Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonistsObsEva SA·Filed 2014·Granted Jun 6, 2017·12 cites·14 claims
- 0284US11419851B2Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2019·Granted Aug 23, 2022·1 cites·6 claims
- 0384US10047048B2Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonistsObsEva SA·Filed 2017·Granted Aug 14, 2018·3 cites·26 claims
- 0484US2024228439A1Pyrrolidine derivatives as oxytocin/vasopressin v1a receptors antagonistsObsEva SA·Filed 2023·Application pending·0 cites
- 0583US10478420B2Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2018·Granted Nov 19, 2019·3 cites·6 claims
- 0683US9962367B2Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2014·Granted May 8, 2018·5 cites·3 claims
- 0782US10604482B2Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonistsObsEva SA·Filed 2018·Granted Mar 31, 2020·2 cites·10 claims
- 0880US9718772B2Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the sameObsEva SA·Filed 2015·Granted Aug 1, 2017·3 cites·5 claims
- 0977US2023097933A1Pyrrolidine derivatives as oxytocin/vasopressin v1a receptors antagonistsObsEva SA·Filed 2022·Application pending·0 cites
- 1077US2023226021A1Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2022·Application pending·0 cites
- 1171US11312683B2Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonistsObsEva SA·Filed 2020·Granted Apr 26, 2022·0 cites·10 claims
- 1263US2016221944A1PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1a RECEPTORS ANTAGONISTSObsEva SA·Filed 2014·Application pending·0 cites
- 1362US2017065556A1Oral formulations of pyrrolidine derivativesObsEva SA·Filed 2014·Application pending·0 cites
- 1458US10752583B2Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the sameObsEva SA·Filed 2017·Granted Aug 25, 2020·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Andre Chollet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →